TNFRSF4 and neoplasm: Patients with high OX40 expression in tumor cells in recurrent cancer biopsies showed a significantly increased chemosensitivity (p = 0.008) and improved 6-month RFS compared to patients with a low count of OX40 positive tumor cells (p = 0.017) (Table 4 and Fig. 2a).